Dyne Therapeutics Inc (DYN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2014 | 12-2013 | 12-2012 | 12-2011 | 12-2010 | |
| Sales | 2,497,000 | 1,466,000 | 1,293,000 | 1,333,000 | 2,059,000 |
| Total expenses | 2,516,000 | 1,784,000 | 1,392,000 | 1,522,000 | 2,091,000 |
| Operating Income | -19,000 | -318,000 | -99,000 | -189,000 | -32,000 |
| Interest Expense | 223,000 | 97,000 | 136,000 | 348,000 | 363,000 |
| Other Income | -26,000 | -2,000 | 243,000 | -38,000 | -58,000 |
| Pre-tax Income | -268,000 | -417,000 | 8,000 | -575,000 | -453,000 |
| Income Tax | -1,000 | -58,000 | -9,000 | -144,000 | -194,000 |
| Net Income Continuous | -267,000 | -359,000 | 17,000 | -431,000 | -259,000 |
| Net Income Discontinuous | N/A | 3,000 | -156,000 | -509,000 | 17,000 |
| Minority Interests | 6,000 | N/A | N/A | N/A | N/A |
| Net Income | $-273,000 | $-356,000 | $-139,000 | $-940,000 | $-242,000 |
| EPS Basic Continuous Ops | -2.54 | -3.59 | -1.13 | N/A | N/A |
| EPS Basic Discontinuous Ops | N/A | 0.03 | 0.06 | N/A | N/A |
| EPS Basic Total Ops | -2.65 | -3.56 | -1.07 | N/A | N/A |
| EPS Diluted Continuous Ops | -2.54 | -3.59 | -1.13 | N/A | N/A |
| EPS Diluted Discontinuous Ops | N/A | 0.03 | 0.06 | N/A | N/A |
| EPS Diluted Total Ops | -2.65 | -3.56 | -1.07 | N/A | N/A |
| EPS Diluted Before Non-Recurring Items | -1.27 | -3.59 | N/A | N/A | N/A |
| EBITDA(a) | $273,000 | $149,000 | $195,000 | $138,000 | $425,000 |